|
USP19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81388237763258E-12 |
| Normal-vs-Stage2 |
3.793200E-04 |
| Normal-vs-Stage3 |
6.19659999978595E-07 |
| Normal-vs-Stage4 |
5.563300E-04 |
| Stage1-vs-Stage2 |
6.238200E-01 |
| Stage1-vs-Stage3 |
1.279640E-01 |
| Stage1-vs-Stage4 |
7.638200E-02 |
| Stage2-vs-Stage3 |
5.244800E-01 |
| Stage2-vs-Stage4 |
2.751400E-01 |
| Stage3-vs-Stage4 |
5.205200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.12843109593086E-14 |
| Normal-vs-AfricanAmerican |
4.43479697409543E-11 |
| Normal-vs-Asian |
2.225800E-02 |
| Caucasian-vs-AfricanAmerican |
5.225200E-01 |
| Caucasian-vs-Asian |
4.106800E-01 |
| AfricanAmerican-vs-Asian |
4.785600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
4.22039999999901E-05 |
| Male-vs-Female |
4.062200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.99629999992391E-08 |
| Normal-vs-Extreme_Weight |
4.55191440096314E-14 |
| Normal-vs-Obese |
2.63639998721032E-09 |
| Normal-vs-Extreme_Obese |
2.588100E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.774800E-01 |
| Normal_Weight-vs-Obese |
4.895200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.376000E-01 |
| Extreme_Weight-vs-Obese |
2.407600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.828400E-01 |
| Obese-vs-Extreme_Obese |
7.834000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.897420E-03 |
| Normal-vs-Age(41-60Yrs) |
1.47239997971838E-11 |
| Normal-vs-Age(61-80Yrs) |
1.84074977482851E-13 |
| Normal-vs-Age(81-100Yrs) |
7.423600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.659200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.754400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.717000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.204800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.759200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.316000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.75289807511103E-11 |
| Normal-VS-Type2 PRCC |
5.8967053462311E-11 |
| Normal-VS-KIRP CIMP |
2.56361598616195E-12 |
| Normal-VS-Unclassified PRCC |
4.519500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.358430E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.762050E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.512800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.174100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.635600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.952600E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.28823684631652E-12 |
| Normal-vs-N1 |
2.39879999974768E-07 |
| Normal-vs-N2 |
1.82329999987019E-08 |
| N0-vs-N1 |
2.939800E-01 |
| N0-vs-N2 |
1.914780E-01 |
| N1-vs-N2 |
4.985200E-01 |
|
|
